Christopher Parkinson
Wolfe Research, LLC

[indiscernible] Right. I think we'll get started. It is with great pleasure that not one, but 2 days in a row, I get to kick off my conference with the 2 most successful DuPont spins of all time. This is obviously my favorite. Don't tell John Kemp upstairs. This time is Corteva, ticker CTVA. Today with us, we have David Johnson, who's the CFO and future CFO of Vylor, the seed spin -- seed and technology, I suppose we should say; and Sam Eathington, who's the Chief Technology Officer, and I think they added digital into your job title as well recently. So obviously, a lot going on, and I'm looking forward to discussing that.

I've had the pleasure of knowing both David and Sam for many years, and I look forward to nerding out for the next half an hour on agriculture. Nothing gets my day started better than that. And I think when I sit down, we have some good news to share with the crowd. So I'm going to drop the prepared questions. So we are joking. I personally thank Chuck for going over to Europe right now and talking to make sure the EU has now officially announced it is, I'd say, beginning to implement the approval of gene editing. Samuel and I were just speaking. This is something we've waited for -- maybe longer for me, 10 years. It's amazing how things can take that long. I'm feeling a little older. I've wife and kids now.